The Chinese Journal of Integrative Medicine, published by SPRINGER, serves as a pivotal platform for advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has been committed to disseminating high-quality research and innovative practices that integrate traditional Chinese medicine with modern medical science. With an impressive categorization in the 2023 metrics, ranking Q2 in Complementary and Alternative Medicine and Q3 in both Medicine (miscellaneous) and Pharmacology (medical), the journal highlights its recognition within the global academic landscape. Researchers and practitioners alike can benefit from its rigorous peer-reviewed articles, making significant contributions to the understanding and application of integrative health strategies. While it currently does not support open access, the journal remains a key resource for those dedicated to exploring the synergy between ancient practices and contemporary medical approaches, thus enhancing patient care and outcomes.

BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

Advances in Traditional Medicine, published by SPRINGER, stands at the forefront of the Complementary and Alternative Medicine field, dedicated to exploring the intricate landscapes of traditional medical practices worldwide. With an impressive 2023 Q2 ranking and a Scopus rank of #30/105, this journal is committed to advancing scholarly discourse and innovation in the study and practice of traditional medicine, making it an essential resource for researchers, practitioners, and students alike. As an Open Access journal, it ensures wide accessibility to cutting-edge research and developments from 2020 to 2024, fostering collaboration and knowledge exchange in the global medical community. Based in Singapore, with operations linked to VAN GODEWIJCKSTRAAT 30, 3311 GZ Dordrecht, Netherlands, this journal not only enhances its reach but also enriches the academic landscape with its significant contributions to understanding the role of traditional medicine in contemporary healthcare.

Current Traditional Medicine, published by Bentham Science Publishers, is an esteemed open-access journal that has been at the forefront of disseminating research in the field of Complementary and Alternative Medicine since its inception in 2015. With ISSN 2215-0838 and E-ISSN 2215-0846, this journal aims to foster scholarly dialogue and innovation by providing a platform for the publication of high-quality studies, reviews, and clinical insights concerning traditional medicine practices and their integration with modern healthcare. Acknowledging the growing relevance of these subjects, Current Traditional Medicine holds a Q3 quartile ranking in Complementary and Alternative Medicine and is positioned within the 30th percentile among its peers. The journal serves as a pivotal resource for researchers, professionals, and students alike, encouraging exploration and advancement in the fields of pharmacology, drug discovery, and herbal medicine. Readily accessible, it ensures that cutting-edge research reaches a global audience, thereby significantly contributing to the evolving landscape of health sciences.

Integrative Cancer Therapies, published by SAGE Publications Inc, is a leading journal dedicated to advancing the multidisciplinary field of cancer treatment through complementary and alternative medicine. With an ISSN of 1534-7354 and an E-ISSN of 1552-695X, this journal has been pivotal in disseminating impactful research since its inception in 2002, establishing itself as a resource for practitioners, researchers, and academicians. As a distinguished publication categorized in the Q1 quartile for Complementary and Alternative Medicine and Q3 for Oncology, it positions itself within the top echelons of its field, as evidenced by its Scopus rankings - 25/105 in Complementary and Alternative Medicine and 178/404 in Oncology. The objective of Integrative Cancer Therapies is to provide a platform for innovative approaches and studies that explore integrative methodologies in cancer care, thereby enhancing therapeutic outcomes and promoting holistic treatment perspectives. Researchers and healthcare professionals who contribute to or follow this journal gain access to cutting-edge findings and diverse perspectives that drive the evolution of cancer therapy.

Journal of Traditional and Complementary Medicine is a distinguished journal in the field of Complementary and Alternative Medicine, published by Elsevier. With an impressive impact factor, the journal is ranked Q1 in its category and boasts a Scopus ranking of #5 out of 105, placing it in the top 5% of relevant journals globally. Since its inception in 2011, the journal has transitioned to an Open Access model in 2015, ensuring that research is accessible to a wider audience. The journal serves as a critical platform for researchers, healthcare professionals, and students to explore and disseminate information about traditional and complementary treatment modalities, bridging the gap between ancient practices and modern medicine. With its commitment to rigorous peer review and an expansive scope encompassing a range of topics related to traditional medicine, the Journal of Traditional and Complementary Medicine continues to play a pivotal role in advancing understanding and application of alternative therapies in healthcare.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.